CureVac
Regina Zeis is a professional with extensive experience in quality validation and assurance within the biotechnology and medical device sectors. Currently serving as Group Manager Quality Validation at CureVac since January 2019, Regina has demonstrated expertise in qualification and validation processes. Prior to this role, Regina worked at BD as a QA-Ingenieur from March 2017 to November 2018. Regina holds a Bachelor of Science degree in Biomedizintechnik/Medizintechnik from Technische Universität Ilmenau, which was obtained between October 2012 and March 2017.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.